Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB A051201 Principal Investigator: Bartlett, Nancy
Title: A Phase I/Randomized Phase II Trial of Idelalisib, Lenalidomide, and Rituximab in Relapsed/Refractory Mantle Cell Lymphoma
Phase: I/II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test the safety of the combination of the drugs lenalidomide and idelalisib at different dose levels, in combination with the drug rituximab and to determine the progression-free survival (PFS) of the combination of lenalidomide and rituximab, with or without idelalisib in a randomized phase II design.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)